UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s Telephone Number, Including Area Code: |
|
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Entry into a Material Definitive Agreement.
On August 19, 2022 the Board of Directors of Cryo-Cell International, Inc. ("Cryo-Cell") declared a one-time, special cash dividend of $0.90 per share of common stock to be paid to its shareholders of record as of the close of business on September 2, 2022 and is expected to be paid on September 9, 2022.
.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
Cryo-Cell International, Inc. |
|
|
|
|
Date: |
August 22, 2022 |
By: |
/s/ David Portnoy |
|
|
|
David Portnoy, Chairman and Co-CEO |
Document And Entity Information |
Aug. 19, 2022 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Aug. 19, 2022 |
Entity Registrant Name | CRYO-CELL INTERNATIONAL, INC. |
Entity Central Index Key | 0000862692 |
Entity Emerging Growth Company | false |
Securities Act File Number | 001-40767 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 22-3023093 |
Entity Address, Address Line One | 700 Brooker Creek Blvd. |
Entity Address, City or Town | Oldsmar |
Entity Address, State or Province | FL |
Entity Address, Postal Zip Code | 34677 |
City Area Code | 813 |
Local Phone Number | 749-2100 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, $0.01 par value |
Trading Symbol | CCEL |
Security Exchange Name | NASDAQ |
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end
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end